Back

prof. dr. S.C. (Sabine) Linn

prof. dr. S.C. (Sabine) Linn

Full Professor

Show full profile

Research Output (142)

High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer:the randomized phase III NeoTN trial

Vliek Sonja, Hilbers Florentine S., van Werkhoven Erik, Mandjes Ingrid, Kessels Rob, Kleiterp Sieta, Lips Esther H., Mulder Lennart, Kayembe Mutamba T., Loo Claudette E., Russell Nicola S., Vrancken Peeters Marie Jeanne T.F.D., Holtkamp Marjo J., Schot Margaret, Baars Joke W., Honkoop Aafke H., Vulink Annelie J.E., Imholz Alex L.T., Vrijaldenhoven Suzan, van den Berkmortel Franchette W.P.J., Meerum Terwogt Jetske M., Schrama Jolanda G., Kuijer Philomeen, Kroep Judith R., van der Padt-Pruijsten Annemieke, Wesseling Jelle, Sonke Gabe S., Gilhuijs Kenneth G.A., Jager Agnes, Nederlof Petra, Linn Sabine C. Dec 2023, In: npj Breast Cancer. 9

External validation and clinical utility assessment of PREDICT breast cancer prognostic model in young, systemic treatment-naïve women with node-negative breast cancer

Wang Yuwei, Broeks Annegien, Giardiello Daniele, Hauptmann Michael, Jóźwiak Katarzyna, Koop Esther A., Opdam Mark, Siesling Sabine, Sonke Gabe S., Stathonikos Nikolas, ter Hoeve Natalie D., van der Wall Elsken, van Deurzen Carolien H.M., van Diest Paul J., Voogd Adri C., Vreuls Willem, Linn Sabine C., Dackus Gwen M.H.E., Schmidt Marjanka K. Dec 2023, In: European Journal of Cancer. 195 11 p.

Luminal breast cancer identity is determined by loss of glucocorticoid receptor activity

Prekovic Stefan, Chalkiadakis Theofilos, Roest Merel, Roden Daniel, Lutz Catrin, Schuurman Karianne, Opdam Mark, Hoekman Liesbeth, Abbott Nina, Tesselaar Tanja, Wajahat Maliha, Dwyer Amy R, Mayayo-Peralta Isabel, Gomez Gabriela, Altelaar Maarten, Beijersbergen Roderick, Győrffy Balázs, Young Leonie, Linn Sabine, Jonkers Jos, Tilley Wayne, Hickey Theresa, Vareslija Damir, Swarbrick Alexander, Zwart Wilbert 2023, In: Embo Molecular Medicine. 15 17 p.

Reply to:Comments on “Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial”

Koole Simone N., Schouten Philip C., van Driel Willemien J., Sonke Gabe S., Linn Sabine C. 1 Dec 2022, In: International Journal of Cancer. 151 , p. 2057-2058 2 p.

Ten-year follow-up of the observational RASTER study, prospective evaluation of the 70-gene signature in ER-positive, HER2-negative, node-negative, early breast cancer

Vliek Sonja B., Hilbers Florentine S., Jager Agnes, Retèl Valesca P., Bueno de Mesquita Jolien M., Drukker Caroline A., Veltkamp Sanne C., Zeillemaker Anneke M., Rutgers Emiel J., van Tinteren Harm, van Harten Wim H., van 't Veer Laura J., van de Vijver Marc J., Linn Sabine C. Nov 2022, In: European Journal of Cancer. 175 , p. 169-179 11 p.

De-escalation of radiotherapy after primary chemotherapy in cT1–2N1 breast cancer (RAPCHEM; BOOG 2010–03):5-year follow-up results of a Dutch, prospective, registry study

de Wild Sabine R., de Munck Linda, Simons Janine M., Verloop Janneke, van Dalen Thijs, Elkhuizen Paula H.M., Houben Ruud M.A., van Leeuwen A. Elise, Linn Sabine C., Pijnappel Ruud M., Poortmans Philip M.P., Strobbe Luc J.A., Wesseling Jelle, Voogd Adri C., Boersma Liesbeth J. Sep 2022, In: The Lancet Oncology. 23 , p. 1201-1210 10 p.

Fertility preservation for women with breast cancer:a multicentre randomized controlled trial on various ovarian stimulation protocols

Balkenende Eva M E, Dahhan Taghride, Beerendonk Catharina C M, Fleischer Kathrin, Stoop Dominic, Lambalk Cornelis B, Bos Annelies M E, Schats Roel, Smeenk Jesper M J, Louwé Leonie A, Cantineau Astrid E P, Bruin Jan Peter de, Linn Sabine C, van der Veen Fulco, van Wely Madelon, Goddijn Mariëtte 1 Jul 2022, In: Human Reproduction. 37 , p. 1786-1794 9 p.

Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based BRCAness tests

Meijer Titia G, Nguyen Luan, Van Hoeck Arne, Sieuwerts Anieta M, Verkaik Nicole S, Ladan Marjolijn M, Ruigrok-Ritstier Kirsten, van Deurzen Carolien H M, van de Werken Harmen J G, Lips Esther H, Linn Sabine C, Memari Yasin, Davies Helen, Nik-Zainal Serena, Kanaar Roland, Martens John W M, Cuppen Edwin, Jager Agnes, van Gent Dik C 24 Jun 2022, In: Oncogene. 41 , p. 3498-3506 9 p.

Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients

de Boo Leonora W., Jóźwiak Katarzyna, Joensuu Heikki, Lindman Henrik, Lauttia Susanna, Opdam Mark, van Steenis Charlaine, Brugman Wim, Kluin Roelof J.C., Schouten Philip C., Kok Marleen, Nederlof Petra M., Hauptmann Michael, Linn Sabine C. 1 Jun 2022, In: British Journal of Cancer. 126 , p. 1401-1409 9 p.

Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer

Van Baelen K, Geukens T, Maetens M, Tjan-Heijnen V, Lord C J, Linn S, Bidard F-C, Richard F, Yang W W, Steele R E, Pettitt S J, Van Ongeval C, De Schepper M, Isnaldi E, Nevelsteen I, Smeets A, Punie K, Voorwerk L, Wildiers H, Floris G, Vincent-Salomon A, Derksen P W B, Neven P, Senkus E, Sawyer E, Kok M, Desmedt C 20 May 2022, In: Annals of oncology : official journal of the European Society for Medical Oncology. 33 , p. 769-785 17 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Contact

Afspraken

Praktisch

hetwkz.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not